Kala Bio (KALA) Operating Expenses (2016 - 2026)

Kala Bio has disclosed Operating Expenses across 11 years of filings, most recently posting $1.7 million for Q2 2026.

• In Q2 2026, Operating Expenses fell 84.39% year-over-year to $1.7 million; the TTM figure through Jun 2026 stood at $21.0 million (down 48.99% YoY), while the FY2025 annual figure was $39.2 million, down 4.45% from the prior year.
• Operating Expenses came in at $1.7 million for Q2 2026 at Kala Bio, down from $1.8 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $32.3 million in Q1 2022 to a low of $1.7 million in Q2 2026.
• Average Operating Expenses over 5 years is $11.6 million, with a median of $10.1 million recorded in 2024.
• Year-over-year, Operating Expenses rose 14.82% in 2025 and slumped 84.39% in 2026.
• Over 5 years, Operating Expenses stood at $10.3 million in 2022, then decreased by 6.17% to $9.6 million in 2023, then decreased by 1.66% to $9.5 million in 2024, then increased by 8.1% to $10.2 million in 2025, then sank by 83.17% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $1.7 million in Q2 2026, $1.8 million in Q1 2026, and $10.2 million in Q4 2025.